Researchers have converted a bacterial toxin into a genome editing tool that, for the first time, can make precise changes to DNA in mitochondria, the cell’s power plants.
The Alzheimer’s epidemic no one is talking about. That’s where the work of Jennifer J. Manly, PhD, a professor of neuropsychology at Columbia University Irving Medical Center, comes in.
Child Neurology Resident Dr. Angela Curcio recently conducted a JCN podcast interview with Pediatric Epileptologist Dr. Rana Said of UT Southwestern Medical Center.
A patient of Dr. Joshua Willey has shared her stroke story, in support of Dr. Willey’s efforts to help the public understand that avoiding hospitals for fear of COVID-19 could have dire consequences.
As important members of our Columbia Neurology community, I am writing to update you on our COVID-19 response efforts, and to detail our plans for gradually resuming our regular clinical services.
Association for Frontotemporal Degeneration (AFTD)
May 8, 2020
Dr. Ted Huey addressed the national FTD community to outline the unique challenges of FTD care during the COVID-19 pandemic and provide guidance to FTD patients, families, and caregivers.
Mitchell Elkind, MD, MS, FAAN, the president-elect of the American Heart Association (AHA), discusses his career, his vision for AHA, and how COVID-19 will change the field of neurology.
